Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 195, Issue 3, Pages 249-262Publisher
SPRINGER
DOI: 10.1007/s10549-022-06680-7
Keywords
Ipsilateral breast tumour recurrence; True recurrence; New primary
Categories
Ask authors/readers for more resources
This study describes the impact of classification methods on ipsilateral breast tumor recurrence, confirming the prognostic value of TR and NP for disease-specific survival and distant metastasis-free survival. It emphasizes the importance of developing and validating a widely accepted classification form.
Purpose Describes the relevance of -various classification methods for ipsilateral breast tumour recurrence (IBTR) as either true recurrence (TR) or new primary (NP) on both disease-specific survival (DSS) and distant metastasis-free survival (DMFS). Method Two hundred and thirty-four of 4359 women undergoing breast-conserving therapy experienced IBTR. We compared the impact of four known classification methods and two newly created classification methods. Results For three of the methods, a better DSS was observed for NP compared to TR with the hazard ratio (HR) ranging from 0.5 to 0.6. The new Twente method classification, comprising all classification criteria of three known methods, and the new Morphology method, using only morphological criteria, had the best HR and confidence interval with a HR 0.5 (95% CI 0.2-1.0) and a HR 0.5 (95% CI 0.3-1.1), respectively. For DMFS, the HR for NP compared to TR ranged from 0.6 to 0.9 for all six methods. The new Morphology method and the Twente method noted the best HR and confidence intervals with a HR 0.6 (95% CI 0.3-1.1) and a HR 0.6 (95% CI 0.4-1.2), respectively. Conclusion IBTR classified as TR or NP has a prognostic value for both DSS and DMFS, but depends on the classification method used. Developing and validating a generally accepted form of classification are imperative for using TR and NP in clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available